Cvrx Inc 9201 West Broadway Ave Ste 650minneapolis Mn 55445 Pma Numberp180050 Supplement Numbers008 Date Received12 23 2022 Decision Date01 20 2023 Product Code Dsr Advisory Committee Cardiovascular Clinical Trialsnct02627196 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Cvrx Inc 9201 West Broadway Ave Ste 650minneapolis Mn 55445 Pma Numberp180050 Supplement Numbers008 Date Received12 23 2022 Decision Date01 20 2023 Product Code Dsr Advisory Committee Cardiovascular Clinical Trialsnct02627196 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P180050S008 CVRx, INC.9201 West Broadway Ave, Ste 650minneapolis, MN 55445 PMA NumberP180050 Supplement NumberS008 Date Received12/23/2022 Decision Date01/20/2023 Product Code DSR  Advisory Committee Cardiovascular Clinical TrialsNCT02627196 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	BAROSTIM NEO® System	2023-01-20